Letters Drug rationing in new NHS

Return of the postcode lottery

BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c7389 (Published 30 December 2010) Cite this as: BMJ 2010;341:c7389
  1. John Graham, consultant in clinical oncology1,
  2. Sam Guglani, consultant in clinical oncology2,
  3. Sean Elyan, consultant in clinical oncology2,
  4. Stephen Falk, consultant in clinical oncology3,
  5. Jeremy Braybrooke, consultant in medical oncology3,
  6. Tom Roques, consultant in clinical oncology4
  1. 1Musgrove Park Hospital, Taunton TA1 5DA, UK
  2. 2Three Counties Cancer Centre, Cheltenham General Hospital, Cheltenham GL53 7AN, UK
  3. 3Bristol Haematology and Oncology Centre, Bristol BS2 8ED, UK
  4. 4Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK
  1. john.graham{at}nhs.net

Many of the issues arising from changes to NHS drug pricing in 2014 already apply to the Interim Cancer Drugs Fund.1 The government’s initial pledge of £50m up to April 2011 has been followed by a proposal for …

View Full Text